Stockreport

CNS Pharmaceuticals Reports First Quarter 2024 Financial Results [Yahoo! Finance]

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF Company committed to addressing the most aggressive type of brain cancer with an average survival of only 14 to 16 months after diagnosis and no cure HOUSTON, TX / AC [Read more]